CN1161135C - Medicine for curing carcinoma of stomach - Google Patents
Medicine for curing carcinoma of stomach Download PDFInfo
- Publication number
- CN1161135C CN1161135C CNB011019573A CN01101957A CN1161135C CN 1161135 C CN1161135 C CN 1161135C CN B011019573 A CNB011019573 A CN B011019573A CN 01101957 A CN01101957 A CN 01101957A CN 1161135 C CN1161135 C CN 1161135C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- medicine
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for treating stomach cancer, which is characterized in that the medicine for treating stomach cancer is coated by capsules by using 20 Chinese herbal medicines, such as hemlock parsley, ledebouriella root, nutgrass galingale rhizome, earthworm, giant typhonium rhizome, areca peel, dried tangerine peel, malt, medicated leaven, chicken's gizzard-membrane, etc., as raw materials, and the medicine for treating stomach cancer has obvious effects on treating the stomach cancer. The present invention relates to a pure Chinese herb preparation without the addition of any additive and toxic or side effects.
Description
The present invention relates to a kind of medicine for the treatment of gastric cancer, specifically it is to be that raw material is made capsule according to a conventional method with the Chinese herbal medicine, is used for the treatment of the medicament of gastric cancer.
Gastric cancer is comparatively to be difficult to one of disease of curing at present, does not still have specific drug so far, and majority is treated with the Chinese medicine and western medicine of mitigate the disease, so effect is bad, and also useful embolic chemotherapy has side effect, the expense height.
Purpose of the present invention just for the shortcoming that overcomes above-mentioned prior art with not enough, be that the medicine of making of raw material is used for the treatment of gastric cancer with the Chinese herbal medicine and provide a kind of, thereby can treat disease effectively.
The objective of the invention is to realize by following technical proposal:
Rhizoma Chuanxiong 5-15 part Radix Saposhnikoviae 5-15 part Rhizoma Cyperi 5-15 part Pheretima 5-15 part Rhizoma Typhonii 5-15 part
Pericarpium Arecae 5-15 part Pericarpium Citri Reticulatae 5-15 part Fructus Hordei Germinatus 15-25 part Massa Medicata Fermentata 15-25 part Endothelium Corneum Gigeriae Galli 5-15 part
Radix Curcumae 5-15 part Radix Bupleuri 5-15 part Radix Astragali 5-15 part Rhizoma Corydalis 5-15 part Radix Angelicae Sinensis 5-15 part
Fructus Schisandrae Chinensis 5-15 part Cortex Cinnamomi 5-15 part Fructus Crataegi 15-25 part Radix Paeoniae Rubra 5-15 part Radix Sophorae Flavescentis 5-15 part.
The weight proportion of each raw material of medicine of the present invention is:
Rhizoma Chuanxiong 8-12 part Radix Saposhnikoviae 5-10 part Rhizoma Cyperi 10-15 part Pheretima 10-15 part Rhizoma Typhonii 10-15 part
Pericarpium Arecae 10-12 part Pericarpium Citri Reticulatae 10-12 part Fructus Hordei Germinatus 20-25 part Massa Medicata Fermentata 12-20 part Endothelium Corneum Gigeriae Galli 8-12 part
Radix Curcumae 10-15 part Radix Bupleuri 8-12 part Radix Astragali 10-15 part Rhizoma Corydalis 8-12 part Radix Angelicae Sinensis 10-15 part
The weight proportion of each raw material of medicine of the present invention is:
10 parts of 15 parts of Pericarpium Arecae of 10 parts of Rhizoma Typhoniis of 12 parts of Pheretimas of 8 portions of Rhizoma Cyperis of 10 parts of Radix Saposhnikoviaes of Rhizoma Chuanxiong
10 parts of 12 parts of Radix Bupleuri of 10 portions of Radix Curcumaes of 15 parts of Endothelium Corneum Gigeriae Galli of 22 parts of Massa Medicata Fermentata of 12 parts of Fructus Hordei Germinatus of Pericarpium Citri Reticulatae
20 parts of 12 portions of Fructus Crataegis of 10 portions of Cortex Cinnamomis of 15 parts of Fructus Schisandrae Chinensis of 10 parts of Radix Angelicae Sinensis of 15 parts of Rhizoma Corydalis of the Radix Astragali
15 parts of 10 parts of Radix Sophorae Flavescentiss of Radix Paeoniae Rubra.
Medicine material of the present invention is according to theory of Chinese medical science, the result who sums up in conjunction with for many years clinical observation, and it is that a kind of taking stopgap measures effected a permanent cure, the medicine for the treatment of both the principal and secondary aspects of a disease uses up to a hundred patients, the effect highly significant, just clinical treatment statistics in recent years is as follows:
Physical data:
100 examples are organized in treatment, male 60 examples, and women 40 examples, the oldest 65 years old, minimum 40 years old, the course of disease is the longest 8 years, and was the shortest 2 years, was the gastric cancer patient with process CT, nuclear magnetic resonance diagnosis all.
Therapeutic Method:
Take medicine of the present invention, every day three times, each four, one month is a course of treatment.
While oral western medicine ATP, coenzyme A, with glucose or saline injection, each 0.5ml, once a day.
Therapeutic outcome:
The treatment group:
Man's 60 example recoveries from illness 50 examples account for 83.3% produce effects, 10 examples and account for 16.7% invalid/total effective rate 100%
Woman's 40 example recoveries from illness 37 examples account for 92.5% produce effects, 3 examples and account for 7.5% invalid/total effective rate 100%
Owing to take technique scheme to make the present invention compared with the prior art have following advantage and effect:
A), medicine of the present invention is pure Chinese medicinal preparation, do not add any additives, have no side effect;
B), therapeutic effect is good, the cure rate height;
C), simple, the raw material of preparation method is easy to get, cost is low.
Embodiment 1:
Get Rhizoma Chuanxiong 10g, Radix Saposhnikoviae 8g, Rhizoma Cyperi 12g, Pheretima 10g, Rhizoma Typhonii 15g, Pericarpium Arecae 10g, Pericarpium Citri Reticulatae 12g, Fructus Hordei Germinatus 22g, Massa Medicata Fermentata 15g, Endothelium Corneum Gigeriae Galli 10g, Radix Curcumae 12g, Radix Bupleuri 10g, Radix Astragali 15g, Rhizoma Corydalis 10g, Radix Angelicae Sinensis 15g, Fructus Schisandrae Chinensis 10g, Cortex Cinnamomi 12g, Fructus Crataegi 20g, Radix Paeoniae Rubra 10g, Radix Sophorae Flavescentis 15g, to make capsule through pulverizing according to a conventional method after the above-mentioned raw materials mixing, every 0.5g, through check, qualified is product.
Embodiment 2:
Get Rhizoma Chuanxiong 5g, Radix Saposhnikoviae 15g, Rhizoma Cyperi 5g, Pheretima 15g, Rhizoma Typhonii 5g, Pericarpium Arecae 15g, Pericarpium Citri Reticulatae 5g, Fructus Hordei Germinatus 25g, Massa Medicata Fermentata 20g, Endothelium Corneum Gigeriae Galli 5g, Radix Curcumae 15g, Radix Bupleuri 5g, Radix Astragali 10g, Rhizoma Corydalis 5g, Radix Angelicae Sinensis 10g, Fructus Schisandrae Chinensis 5g, Cortex Cinnamomi 15g, Fructus Crataegi 15g, Radix Paeoniae Rubra 15g, Radix Sophorae Flavescentis 5g, to make capsule through pulverizing according to a conventional method after the above-mentioned raw materials mixing, every 0.5g, through check, qualified is product.
Embodiment 3:
Get Rhizoma Chuanxiong 15g, Radix Saposhnikoviae 5g, Rhizoma Cyperi 15g, Pheretima 5g, Rhizoma Typhonii 10g, Pericarpium Arecae 5g, Pericarpium Citri Reticulatae 15g, Fructus Hordei Germinatus 15g, Massa Medicata Fermentata 25g, Endothelium Corneum Gigeriae Galli 15g, Radix Curcumae 5g, Radix Bupleuri 15g, Radix Astragali 5g, Rhizoma Corydalis 5g, Radix Angelicae Sinensis 5g, Fructus Schisandrae Chinensis 15g, Cortex Cinnamomi 5g, Fructus Crataegi 25g, Radix Paeoniae Rubra 5g, Radix Sophorae Flavescentis 10g, to make capsule through pulverizing according to a conventional method after the above-mentioned raw materials mixing, every 0.5g, through check, qualified is product.
Claims (2)
1, a kind of medicine for the treatment of gastric cancer is characterized in that it makes capsule through pulverizing according to a conventional method by the following weight proportion raw material:
Rhizoma Chuanxiong 5-15 part Radix Saposhnikoviae 5-15 part Rhizoma Cyperi 5-15 part Pheretima 5-15 part Rhizoma Typhonii 5-15 part
Pericarpium Arecae 5-15 part Pericarpium Citri Reticulatae 5-15 part Fructus Hordei Germinatus 15-25 part Massa Medicata Fermentata 15-25 part Endothelium Corneum Gigeriae Galli 5-15 part
Radix Curcumae 5-15 part Radix Bupleuri 5-15 part Radix Astragali 5-15 part Rhizoma Corydalis 5-15 part Radix Angelicae Sinensis 5-15 part
Fructus Schisandrae Chinensis 5-15 part Cortex Cinnamomi 5-15 part Fructus Crataegi 15-25 part Radix Paeoniae Rubra 5-15 part Radix Sophorae Flavescentis 5-15 part.
2, the Chinese medicine of treatment gastric cancer according to claim 1, wherein the weight proportion of each raw material is:
10 parts of 15 parts of Pericarpium Arecae of 10 parts of Rhizoma Typhoniis of 12 parts of Pheretimas of 8 portions of Rhizoma Cyperis of 10 parts of Radix Saposhnikoviaes of Rhizoma Chuanxiong
10 parts of 12 parts of Radix Bupleuri of 10 portions of Radix Curcumaes of 15 parts of Endothelium Corneum Gigeriae Galli of 22 parts of Massa Medicata Fermentata of 12 parts of Fructus Hordei Germinatus of Pericarpium Citri Reticulatae
20 parts of 12 portions of Fructus Crataegis of 10 portions of Cortex Cinnamomis of 15 parts of Fructus Schisandrae Chinensis of 10 parts of Radix Angelicae Sinensis of 15 parts of Rhizoma Corydalis of the Radix Astragali
15 parts of 10 parts of Radix Sophorae Flavescentiss of Radix Paeoniae Rubra.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011019573A CN1161135C (en) | 2001-01-19 | 2001-01-19 | Medicine for curing carcinoma of stomach |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011019573A CN1161135C (en) | 2001-01-19 | 2001-01-19 | Medicine for curing carcinoma of stomach |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1364589A CN1364589A (en) | 2002-08-21 |
| CN1161135C true CN1161135C (en) | 2004-08-11 |
Family
ID=4652342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011019573A Expired - Fee Related CN1161135C (en) | 2001-01-19 | 2001-01-19 | Medicine for curing carcinoma of stomach |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1161135C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100364575C (en) * | 2005-09-02 | 2008-01-30 | 刘庆荣 | Chinese medicinal powder with earthworm and medicated leaven for treating gastric disease |
| CN103919887B (en) * | 2014-03-11 | 2015-11-18 | 北京亚东生物制药有限公司 | A kind of Chinese medicine composition for the treatment of tumor and preparation method thereof |
-
2001
- 2001-01-19 CN CNB011019573A patent/CN1161135C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1364589A (en) | 2002-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101530599B (en) | A pharmaceutical composition for treating mental depression | |
| CN1099983A (en) | Medicine for treating rheumatoid or rheumatic arthritis and hyperosteogeny, and method for preparing same | |
| CN1679864A (en) | Chinese medicine preparation for treating bronchitis | |
| CN101091769B (en) | Medicine for treating and preventing esophagus cancer and gastric cancer, and preparation method | |
| CN1294015A (en) | Medicine for treating thyroid enlargement and thyroidism | |
| CN103405719A (en) | Medicament for treatment of depression | |
| CN1161135C (en) | Medicine for curing carcinoma of stomach | |
| CN102973758A (en) | Traditional Chinese medicine composition for treating depression | |
| CN1317315A (en) | Tendon-comfortable analgesic | |
| CN1111046C (en) | Chinese medicine preparation for curing postpartum disease of woman | |
| CN101249246B (en) | Proprietary Chinese medicine preparations for curing depression after cerebral infarction | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN1954877A (en) | Chinese medicinal composite for treating ischemic necrosis of femoral head and its preparation method | |
| CN1078905A (en) | A kind of medicine for external use for the treatment of hepatopathy | |
| CN1055242C (en) | Chinese medicine for curing aseptic necrosis of head of femur | |
| CN1799614A (en) | Chinese traditional medicine composition for treating liver and kidney diseases and preparation method thereof | |
| CN1136899C (en) | Chinese medicine for treating mastoplasia | |
| CN108635457A (en) | A kind of Chinese medicine composition and the preparation method and application thereof for treating constipation | |
| CN103948878A (en) | Traditional Chinese medicinal composition for treating bone diseases | |
| CN102416147B (en) | Medicinal composition for treating mania of patients abstained from drugs | |
| CN1302639A (en) | Tendon-conditioning analgetic | |
| CN101766714A (en) | Oral preparation for treating hernia | |
| CN1156292C (en) | Medicine for curing cholecystitis and its preparing method | |
| CN100345582C (en) | Medicine for abstaining from drug | |
| CN1907396A (en) | Medicine for treating cerebral hemorrhage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |